Stay updated on Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Sign up to get notified when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.

Latest updates to the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page
- Check2 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the history page, signaling a newer software release. This is a non-content change reflecting an update to the page's underlying system.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study history now shows 'Check who can join' and 'Find Contact Information' for easier participation and outreach. The revision label updates from v3.5.5 to v3.6.0.SummaryDifference0.6%

- Check23 days agoChange DetectedA new revision entry v3.5.5 was added to the study record history, and the previous revision v3.5.4 was removed, indicating an updated version in the record history.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision: v3.5.4 is now shown on the page, replacing the previous v3.5.3. This reflects a new build of the ClinicalTrials.gov record view.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page’s footer/version indicator has been updated from Revision v3.5.2 to v3.5.3, reflecting a maintenance or release update to how the site is presented rather than any change to the study content.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.5.2 has been added; Revision: v3.5.0 has been removed.SummaryDifference0.1%

Stay in the know with updates to Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fulvestrant & Pyrotinib in HR+/HER2+ Clinical Trial page.